Regulation of telomerase and its hTERT messenger in colorectal cancer

Oncology Reports

Volumn 11, Issue 2, 2004, Pages 395-400

  Boldrini, Laura ^a   Faviana, Pinuccia ^a   Gisfredi, Silvia ^a   Donati, Valentina ^a   Zucconi, Ylenia ^a   Ursino, Silvia ^a   Simi, Paolo ^a   Baldinotti, Fulvia ^a   Berti, Piero ^a   Galleri, Davide ^a   Materazzi, Gabriele ^a   Basolo, Fulvio ^a   Miccoli, Paolo ^a   Pingitore, Raffaele ^a   Fontanini, Gabriella ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

hTERT; p53; Telomerase activity

Indexed keywords

DNA; DNA BINDING PROTEIN; MESSENGER RNA; PROTEIN P53; TELOMERASE;

ADENOCARCINOMA; AMINO ACID SUBSTITUTION; ARTICLE; CODON; COLON TUMOR; COLORECTAL TUMOR; GENE DELETION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; NUCLEOTIDE REPEAT; PATHOLOGY; POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; AMINO ACID SUBSTITUTION; CODON; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; DNA, NEOPLASM; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HUMANS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; REPETITIVE SEQUENCES, NUCLEIC ACID; RNA, MESSENGER; SEQUENCE DELETION; TELOMERASE; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 3242803048     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.11.2.395     Document Type: Article

References (48)

1. Greider CW: Telomere length regulation. Annu Rev Biochem 65: 337-365, 1996.
2. Meyerson M: Role of telomerase in normal and cancer cells. J Clin Oncol 18: 2626-2634, 2000.
3. Shay JW and Bacchetti S: A survey of telomerase activity in human cancer. Europ J Cancer 33: 787-791, 1997.
4. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA and Shay JW: Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med 1: 249-255, 1995.
5. Hiyama K, Hiyama E, Ishioka S, Yakamido M, Inai K, Gazdar AF, Piatyszek MA and Shay JW: Telomerase activity in small-cell and non-small-cell lung cancers. J Natl Cancer Inst 87: 895-902, 1995.
6. Hiyama E, Okayama T, Tatsumoto N, Hiyama K, Imamura Y, Murakami Y, Kodarna T, Piatyszek MA, Shay JW and Matsuura Y: Telomerase activity in gastric cancer. Cancer Res 55: 3258-3262, 1995.
7. Chadeneau C, Hay K, Hirte HW, Gallinger S and Bacchetti S: Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 55: 2533-2536, 1995.
8. Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Ligner J, Harley CB and Cech TR: Telomerase sub-unit homologs from fission yeast and human. Science 277: 955-959, 1997. (Pubitemid 27366681)
9. Suzuki T, Suzuki Yand Fujioka T: Expression of the catalytic subunit associated with telomerase gene in human urinary bladder cancer. J Urol 162: 2217-2220, 1999.
10. Jong HS, Park YI, Kim S, Sohn JH, Kang SH, Song SH, Bang YJ and Kim NK: Up-regulation of human telomerase catalytic subunit during gastric carcinogenesis. Cancer 86: 559-565, 1999. (Pubitemid 29379400)
11. Kyo S, Kanaya T, Takakura M, Tanaka M, Yamashita A, Inoue H and Inoue M: Expression of human telomerase subunits in ovarian malignant, borderline and benign tumours. Int I Cancer 80: 804-809, 1999. (Pubitemid 29108852)
12. Wu A, Ichihashi MM and Ueda M: Correlation of the expression of human telomerase activity in normal skin and skin tumours. Cancer 86: 2038-2044, 1999.
13. Wisman GB, De Jong S, Meersma GJ, Helder MN, Hollema H, De Vries EG, Keith WN and van Der Zee AG: Telomerase in (pre) neoplastic cervical disease. Hum Pathol 31: 1304-1312, 2000.
14. Kilian A, Bowtell DD, Abud HE, Hime GR, Venter DJ, Keese PK, Duncan EL, Reddel RR and Jefferson RA: Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet 6: 2011-2019, 1997. (Pubitemid 27477942)
15. Wick M, Zubov D and Hagen G: Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT). Gene 232: 97-106, 1999. (Pubitemid 29305322)
16. Boldrini L, Faviana P, Gisfredi S, Zucconi Y, Di Quirico D, Donati V, Berti P, Spisni R, Galleri D, Materazzi G, Basolo F, Miccoli P, Pingitore R and Fontanini G: Evaluation of telomerase in the development and progression of colon cancer. Int J Mol Med 10: 589-592, 2002.
17. Boldrini L, Faviana P, Gisfredi S, Zucconi Y, Di Quirico D, Donati V, Berti P, Spisni R, Galleri D, Materazzi G, Basolo F, Miccoli P, Pingitore R and Fontanini G: Evaluation of telomerase mRNA (hTERT) in colon cancer. Int J Oncol 21: 493-497, 2002.
18. Landberg G, Nielsen NH, Nilsson P, Emdin SO, Cajander J and Roos G: Telomerase activity is associated with cell circle deregulation in human breast cancer. Cancer Res 57: 549-554, 1997. (Pubitemid 27081678)
19. Faraoni I, Turriziani M, Masci G, De Vecchis I, Shay JW, Bonmassar E and Graziani G: Decline in telomerase activity as a measure of tumor cell killing by antineoplastic agents in vitro. Clin Cancer Res 3: 579-585, 1997. (Pubitemid 27211836)
20. Asker C, Wiman KG and Selivanova G: p53-induced apoptosis as a safeguard against cancer. Biochem Biophy Res Commun 265: 1-6, 1999.
21. Gottlieb TM and Oren M: p53 and apoptosis. Sem Cancer Biol 8: 359-368, 1998. (Pubitemid 29131357)
22. Hollstein M, Rice K, Greenblatt MS, Soussi T, Fuchs R, Sorlie T, Hovig E, Smith-Sorensen B, Montesano R and Harris CC: Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res 22: 3551-3555, 1994. (Pubitemid 24299821)
23. Gayet J, Zhou XP, Duval A, Rolland S, Hoang JM, Cottu P and Hamelin R: Extensive characterization of genetic alterations in a series of human colorectal cancer cell lines. Oncogene 20: 5025-5032, 2001. (Pubitemid 32769792)
24. Samowitz WS, Curtin K, Ma KN, Edwards S, Schaffer D, Leppert MF and Slattery ML: Prognostic significance of p53 mutations in colon cancer at the population level. Int I Cancer 99:597-602, 2002. (Pubitemid 34461615)
25. Faviana P, Boldrini L, Spisni R, Berti P, Galleri D, Biondi R, Camacci T, Materazzi G, Pingitore R, Miccoli P and Fontanini G: Neoangiogenesis in colon cancer: Correlation between vascular density, vascular endothelial growth factor (VEGF) and p53 protein expression. Oncol Rep 9: 617-620, 2002.
26. Boldrini L, Faviana P, Pistoiesi F, Gisfredi S, Di Quirico D, Lucchi M, Mussi A, Angeletti CA, Baldinotti F, Fogli A, Simi P, Basolo F, Pingitore R and Fontanini G: Alterations of Fas (Apo-1/CD95) gene and its relationship with p53 in non small cell lung cancer. Oncogene 20: 6632-6637, 2001. (Pubitemid 32980290)
27. Piatyszek MA, Kim NW, Weinrich SL, Hiyama K, Hyiama E, Wright WE and Shay JW: Detection of telomerase activity in human cells and tumours by telomeric repeat amplification protocol (TRAP). Methods Cell Sci 17: 1-15, 1995.
28. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL and Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015, 1994.
29. Ulaner GA, Hu J-F, Vu TH, Giudice LC and Hoffman AR: Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res 58: 4168-4172, 1998. (Pubitemid 28440575)
30. Wizigmann-Voos S, Breier G, Risau W and Plate KH: Upregulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas. Cancer Res 55: 1358-1364, 1995.
31. Martens UM, Zijlmans JMJM, Poon SSS, Dragowska W, Yui J, Chavez EA, Ward RKm and Lansdorp PM: Short telomeres on human chromosome 17p. Nat Genet 18: 76-80, 1998. (Pubitemid 28027885)
32. Hiyama K, Ishioka S, Shirotani Y, Inai K, Hiyama E, Murakami I, Isobe T, Inamizu T and Yamakido M: Alterations in telomeric repeat length in lung cancer are associated with loss of heterozygosity in p53 and Rb. Oncogene 10: 937-944, 1995.
33. Gollahon LS, Kraus E, Wu T-A, Yim SO, Strong LC, Shay JW and Tainsky MA: Telomerase activity during spontaneous immortalization of Li-Fraumeni syndrome skin fibroblasts. Oncogene 17:709-717, 1998. (Pubitemid 28412491)
34. Mukhopadhyay T, Multani AS, Roth JA and Pathak S: Reduced telomeric signals and increased telomeric associations in human lung cancer cell lines undergoing p53-mediated apoptosis. Oncogene 17: 901-906, 1998. (Pubitemid 28430212)
35. Kusumoto M, Ogawa T, Mizumoto K, Ueno K, Niiyama H, Sato N, Nakamura M and Tanaka M: Adenovirus-mediated p53 gene transduction inhibits telomerase activity independent of its effects on cell cycle arrest and apoptosis in human pancreatic cancer cells. Clin Cancer Res 5: 2140-2147, 1999. (Pubitemid 29399270)
36. Kanaya T, Kyo S, Hamada K, Takakura M, Kitagawa Y, Harada H and Inoue M: Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription. Clin Cancer Res 6: 1239-1247, 2000. (Pubitemid 30226203)
37. Xu D, Wang Q, Gruber A, Bjorkholm M, Chen Z, Zaid A, Selivanova G, Peterson C, Wiman KG and Pisa P: Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells. Oncogene 19: 5123-5133, 2000.
38. Loveday RL, Greenman J, Drew PJ, Monson JRT and Kerin MJ: Genetic changes associated with telomerase activity in breast cancer. Int J Cancer 84: 516-520, 1999.
39. Roos G, Nilsson P, Cajander S, Nielsen NH, Arnerlov C and Landberg G: Telomerase activity in relation to p53 status and clinical-pathological parameters in breast cancer. Int J Cancer 79: 343-348, 1998. (Pubitemid 28359730)
40. Wu X, Kemp B, Amos CI, Honn SE, Zhang W, Walsh GL and Spitz MR: Associations among telomerase activity, p53 protein over-expression, and genetic instability in lung cancer. Br J Cancer 80: 453-457, 1999. (Pubitemid 29213200)
41. Maxwell SA, Capp D and Acosta SA: Telomerase activity in immortalized endothelial cells undergoing p53-mediated apoptosis. Biochem Biophys Res Commun 241: 642-645, 1997. (Pubitemid 28036710)
42. Milner J, Medcalf EA and Cook AC: Tumor suppressor p53: analysis of wild-type and mutant p53 complexes. Mol Cell Biol 11: 12-19, 1991. (Pubitemid 21895176)
43. Ko LJ and Prives C: p53: puzzle and paradigm. Genes Dev 10: 1054-1072, 1996. (Pubitemid 26152848)
44. Bargonetti J, Chicas A, White D and Prives C: p53 represses Spi DNA binding and HIV-LTR directed transcription. Cell Mol Biol 43: 935-949, 1997.
45. Li H, Cao Y, Berndt MC, Funder JWand Liu JP: Molecular interactions between telomerase and the tumor suppressor protein p53 in vitro. Oncogene 18: 6785-6794, 1999.
46. Cong YS, Wen J and Bacchetti S: The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter. Hum Mol Genet 8: 137-142, 1999. (Pubitemid 29039059)
47. Bryan TM, Englezou A, Gupta J, Bacchetti S and Reddel RR: Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 14: 4240-4248, 1995.
48. Bryan TM, Englezou A, Dalia-Pozza L, Dunham MA and Reddel RR: Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med 3 :1271-1274, 1997. (Pubitemid 27508830)